Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Novo Nordisk
Market Cap: DKK 2.0t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 439.60
7D
-2.5%
1Y
-56.2%
Zealand Pharma
Market Cap: DKK 25.2b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 354.70
7D
-3.8%
1Y
-61.1%
Bavarian Nordic
Market Cap: DKK 13.2b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 168.95
7D
0.09%
1Y
-1.6%
Gubra
Market Cap: DKK 7.6b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 465.20
7D
-8.8%
1Y
-22.7%
NTG Nordic Transport Group
Market Cap: DKK 4.1b
Provides asset-light freight forwarding services through road, rail, air, and ocean in Denmark, Sweden, the United States, Germany, Finland, and internationally.
NTG
DKK 188.60
7D
4.7%
1Y
-39.0%
Nilfisk Holding
Market Cap: DKK 2.4b
Develops, manufactures, and sells cleaning solutions and services worldwide.
NLFSK
DKK 88.00
7D
1.3%
1Y
-38.8%
BioPorto
Market Cap: DKK 638.3m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.40
7D
1.4%
1Y
-32.5%
Green Hydrogen Systems
Market Cap: DKK 77.2m
Develops and produces electrolysers for hydrogen production based on renewable energy in United Kingdom, Norway, Chile, and Switzerland.
GREENH
DKK 0.41
7D
0%
1Y
-95.4%